September 5, 2024 Cystic Fibrosis Therapeutics Development Network Contributes New Data Sets to C-Path’s RDCA-DAP, Advancing CF Research and Treatment Strategies Critical Path Institute (C-Path) today announced the addition of significant new data sets...
October 1, 2024-October 2, 2024 Join C-Path at the Health Research Alliance Fall Conference C-Path's Maaike Everts, PhD, Executive Director of its Translational Therapeutics Accelerate (TRxA), is participating in...
October 23, 2024-October 27, 2024 American Society of Nephrology (ASN) Kidney Week 2024 BmDR Oversight Committee members Nicholas King, Katrina Peron, and Gary Friedman will be attending ASN Kidney Week 2024 in....
August 29, 2024 ASN 2024 Poster: EL-PFDD v SONG: PKDOC, the PKD Foundation, and the ARPKD community hosted an Externally-led Patient Focused Drug Development (EL-PFDD) meeting...
August 22, 2024 C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research and Drug Development C-Path is thrilled to announce its CPLD Consortium has been awarded a grant from the Ara Parseghian...
August 22, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project in Prostate Cancer C-Path proudly announced today a $250,000 grant award to Peter Wipf, Ph.D...
August 20, 2024 C-Path Receives Data Transfer from The Champ Foundation Registry C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...
August 20, 2024 C-Path’s RDCA-DAP Announces Strategic Partnership with Vivli to Enhance Clinical Trials Data Sharing for Rare Diseases C-Path today announced a strategic data sharing partnership with Vivli, the nonprofit...
August 15, 2024 Clinical Outcome Assessments — Second Public Discussion Enjoy the recording and slides from this August 15 CP-RND webinar.
August 13, 2024 C-Path’s TRxA Announces $250,000 Grant for Drug Development Project on Antibiotic-Resistant Gram-Negative Bacteria C-Path) Translational Therapeutics Accelerator (TRxA) announced today that Kenneth Keiler...